Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Pathway for Softgel vs Tablet Comparison [Design Issues]

posted by jag009 – NJ, 2018-05-18 18:33 (2955 d 14:06 ago) – Posting: # 18786
Views: 4,064

Hi,

❝ However I have a case where a BE study was conducted comparing Metronidazole tablet (Reference) with Metronidazole soft gel (test). Both were IR. Is this acceptable?

Have you read this guidance? FDA

John

Complete thread:

Bioequivalence of IR vs MR tablet heritage 2018-05-05 06:25
- Consider 505(b)(2) Pathway bebac_fan 2018-05-05 17:08
  - Pathway for Softgel vs Tablet Comparison Obinoscopy 2018-05-15 19:04
    - Pathway for Softgel vs Tablet Comparisonjag009 2018-05-18 16:33

Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
155 visitors (0 registered, 155 guests [including 14 identified bots]).
Forum time: 08:39 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic. Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz